VanEck Biotech ETF (BBH)

NasdaqGM • Currently down 5.14 (-2.12%) in today's trading session

2 members of Congress have disclosed 6 trades in VanEck Biotech ETF (BBH) via STOCK Act filings. The most recent disclosure was a sale by Thomas R. Suozzi on 4 March 2022. The most active traders have been Thomas R. Suozzi (4) and Donald S. Beyer (2). Aggregate disclosed activity totals roughly $158K in purchases and $158K in sales (midpoint estimates from bracketed disclosure amounts).

VanEck Biotech ETF is currently trading at $236.85, positioned at 91% of its 52-week range ($160.91 – $244.35).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$236.85
24h Change
-5.14 (-2.12%)
52 Week Range
$160.91—$244.35
View on NASDAQ

VanEck Biotech ETF Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BBH

Select to highlight on chart
4 transactions
Compliance: 67%
Thomas R. Suozzi4 Mar 202220 May 2022SaleStock$50,001 - $100,000N/A
Donald S. Beyer28 Jan 20221 Feb 2022SaleStock$1,001 - $15,000N/A
Donald S. Beyer22 Dec 20211 Jan 2022PurchaseStock$1,001 - $15,000N/A
Thomas R. Suozzi20 Oct 20215 Nov 2021PurchaseStock$50,001 - $100,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$456.31M

Volume

5.57K

Beta

0.56

P/E Ratio

29.44

Fundamentals

EPS

$8.05

Div. Yield

0.40%

Open

$239.66

Day Range

$236.62 — $239.71

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
1999-11-23
Website
www.vaneck.com/us/en/investments/biotech-etf-bbh

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations...

No earnings data available for this stock.

Dividends

Dividend History

22 Dec 2025
Amount $0.9565
23 Dec 2024
Amount $1.2517
18 Dec 2023
Amount $0.7127
19 Dec 2022
Amount $0.7490
20 Dec 2021
Amount $0.3970
21 Dec 2020
Amount $0.6080
23 Dec 2019
Amount $0.4720
20 Dec 2018
Amount $0.5510
18 Dec 2017
Amount $0.6830
19 Dec 2016
Amount $0.3270
21 Dec 2015
Amount $0.3370
23 Dec 2013
Amount $0.0030
24 Dec 2012
Amount $0.1840
6 Dec 2012
Amount $0.0600
13 Nov 2012
Amount $0.2121
5 Sept 2012
Amount $0.0056
29 Aug 2012
Amount $1.1400
14 Aug 2012
Amount $0.2121
14 May 2012
Amount $0.2321
7 Mar 2012
Amount $0.0258
14 Feb 2012
Amount $0.2121
15 Nov 2011
Amount $0.0603
7 Sept 2011
Amount $0.0017
16 Aug 2011
Amount $0.0603
26 May 2011
Amount $0.1067
26 Apr 2011
Amount $3.4533
9 Mar 2011
Amount $0.0073
9 Sept 2010
Amount $0.0015
11 Mar 2010
Amount $0.0063
30 Oct 2009
Amount $0.4497
9 Sept 2009
Amount $0.0013
1 Apr 2009
Amount $27.8587
11 Mar 2009
Amount $0.0053
3 Dec 2008
Amount $1.0890
11 Sept 2008
Amount $0.0015
1 Sept 2008
Amount $0.0025
1 Jun 2008
Amount $0.0025
21 May 2008
Amount $0.9969
12 Mar 2008
Amount $0.0043
2 Mar 2008
Amount $0.0025
2 Dec 2007
Amount $0.0025
13 Sept 2007
Amount $0.0015
3 Sept 2007
Amount $0.0025
27 Jun 2007
Amount $2.8910
31 May 2007
Amount $0.0025
14 Mar 2007
Amount $0.0037
28 Feb 2007
Amount $0.0025
5 Feb 2007
Amount $0.4533
30 Nov 2006
Amount $0.0025
14 Sept 2006
Amount $0.0013
31 Aug 2006
Amount $0.0025
31 May 2006
Amount $0.0025
26 Apr 2006
Amount $2.5600
16 Apr 2006
Amount $0.0030
28 Feb 2006
Amount $0.0025
30 Nov 2005
Amount $0.0025
15 Sept 2005
Amount $0.0012
31 Aug 2005
Amount $0.0025
31 May 2005
Amount $0.0025
17 Mar 2005
Amount $0.0026
28 Feb 2005
Amount $0.0025
30 Nov 2004
Amount $0.0025
16 Sept 2004
Amount $0.0012
31 Aug 2004
Amount $0.0025
31 May 2004
Amount $0.0025
29 Feb 2004
Amount $0.0025
30 Nov 2003
Amount $0.0025
1 Sept 2003
Amount $0.0025
1 Jun 2003
Amount $0.0025
2 Mar 2003
Amount $0.0025
1 Dec 2002
Amount $0.0025
2 Sept 2002
Amount $0.0025
17 Jul 2002
Amount $0.6280
2 Jun 2002
Amount $0.0025
27 Feb 2002
Amount $0.0027
2 Dec 2001
Amount $0.0025
3 Sept 2001
Amount $0.0025
31 May 2001
Amount $0.0025
28 Feb 2001
Amount $0.0025
30 Nov 2000
Amount $0.0025
30 Aug 2000
Amount $0.0025
31 May 2000
Amount $0.0025
29 Feb 2000
Amount $0.0025

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BBH

Which members of Congress have traded BBH?
2 members of Congress have disclosed 6 trades in VanEck Biotech ETF (BBH) under the STOCK Act. The most active traders are Thomas R. Suozzi and Donald S. Beyer.
When was BBH most recently disclosed by Congress?
The most recent BBH disclosure was a sale by Thomas R. Suozzi on 4 March 2022.
What is the total disclosed congressional trading volume for BBH?
Members of Congress have disclosed approximately $158K in BBH purchases and $158K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BBH?
This BBH page updates as soon as new STOCK Act disclosures are filed for VanEck Biotech ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.